JP2010521519A5 - - Google Patents

Download PDF

Info

Publication number
JP2010521519A5
JP2010521519A5 JP2009554033A JP2009554033A JP2010521519A5 JP 2010521519 A5 JP2010521519 A5 JP 2010521519A5 JP 2009554033 A JP2009554033 A JP 2009554033A JP 2009554033 A JP2009554033 A JP 2009554033A JP 2010521519 A5 JP2010521519 A5 JP 2010521519A5
Authority
JP
Japan
Prior art keywords
testosterone
boy
treatment
adolescent
age
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009554033A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010521519A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/053372 external-priority patent/WO2008116825A2/en
Publication of JP2010521519A publication Critical patent/JP2010521519A/ja
Publication of JP2010521519A5 publication Critical patent/JP2010521519A5/ja
Pending legal-status Critical Current

Links

JP2009554033A 2007-03-23 2008-03-20 小児性腺機能低下症の治療用組成物及び治療方法 Pending JP2010521519A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07104726 2007-03-23
PCT/EP2008/053372 WO2008116825A2 (en) 2007-03-23 2008-03-20 Compositions and method for treating pediatric hypogonadism

Publications (2)

Publication Number Publication Date
JP2010521519A JP2010521519A (ja) 2010-06-24
JP2010521519A5 true JP2010521519A5 (enExample) 2011-05-06

Family

ID=38321980

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009554033A Pending JP2010521519A (ja) 2007-03-23 2008-03-20 小児性腺機能低下症の治療用組成物及び治療方法

Country Status (10)

Country Link
EP (1) EP2136813A2 (enExample)
JP (1) JP2010521519A (enExample)
CN (1) CN101754764A (enExample)
AU (1) AU2008231781B2 (enExample)
BR (1) BRPI0809124A8 (enExample)
CA (1) CA2623477C (enExample)
EA (1) EA018775B1 (enExample)
IL (1) IL200887A0 (enExample)
MX (1) MX2009008995A (enExample)
WO (1) WO2008116825A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3755B1 (ar) * 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
JP6152092B2 (ja) * 2011-05-15 2017-06-28 エーセラス ファーマシューティカルズ コーポレーション 経鼻投与のための徐放テストステロン鼻腔内ゲル、方法および複数回用量プレフィルアプリケーターシステム

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
US7138389B2 (en) * 2004-02-09 2006-11-21 University Of Washington Oral androgen therapy using modulators of testosterone bioavailability
CA2624788C (en) * 2005-10-12 2011-04-19 Unimed Pharmaceuticals, Llc Improved testosterone gel and method of use

Similar Documents

Publication Publication Date Title
ATE511847T1 (de) Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes
NZ609719A (en) Pharmaceutical composition
BR0113663A (pt) Composições de pelìcula de pectina
EA201490876A1 (ru) Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей
AR063201A1 (es) Composiciones farmaceuticas de ropinirol y metodos de uso de las mismas
MX2011010347A (es) Derivados sustituidos de azoantraceno, composiciones farmaceuticas y metodos de uso de los mismos.
WO2009152189A8 (en) Low dose topiramate/phentermine compostion and methods of use thereof
EA200800064A1 (ru) Композиция в виде гранул с модифицированным и немедленным высвобождением мемантина
JP2013526620A5 (enExample)
MX2010004613A (es) Composicion topica.
EA201170117A1 (ru) Противоаллергические биополимеры морского происхождения
JP2010520246A5 (enExample)
JP2011026348A5 (enExample)
WO2009004995A1 (ja) 生理活性物質を定着および発現させる方法
ES2720954T3 (es) Formulaciones estabilizadas de estatina
JP2013510169A5 (enExample)
HRP20211817T1 (hr) Postupak adjuvantnog liječenja raka
EP1885380A4 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ARSENE (III ACID), SODIUM SALT AND THEIR DERIVATIVES FOR THE TREATMENT OF UROGENITAL CANCER AND METASTASES THEREOF
ITMI20030195A1 (it) Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose
BR112015019776A2 (pt) comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e métodos de uso dos comprimidos
MX2007008141A (es) Composicion farmaceutica de sustancias labiles en medio acido.
FI20095606A7 (fi) Järjestelmä ja menetelmä alhaisen suspendoituneen kiintoainepitoisuuden omaavan liuoksen tuottamiseksi ja sellaisen liuoksen käyttö
EP2251016A3 (en) Topical use of hyaluronic acid with folmogenic action for the treatment and prophylaxys of pathologies of the respiratory tract.
WO2009041111A1 (ja) 経口投与剤
JP2009522376A5 (enExample)